Monoclonal Antibodies and Their Functional Fragments in Research, Diagnosis and Therapy 2.0

Monoclonal antibodies (mAbs) are among the most specialised molecules for the recognition and capture of specific analytes. Hundreds of thousands of mAbs have been generated for a large number of different antigens with increasing affinity and specificity and are available for the most diverse purpo...

Full description

Saved in:
Bibliographic Details
Other Authors: Ruvo, Menotti (Editor), Sandomenico, Annamaria (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_79602
005 20220321
003 oapen
006 m o d
007 cr|mn|---annan
008 20220321s2022 xx |||||o ||| 0|eng d
020 |a books978-3-0365-3164-9 
020 |a 9783036531656 
020 |a 9783036531649 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-3164-9  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a GP  |2 bicssc 
072 7 |a PS  |2 bicssc 
100 1 |a Ruvo, Menotti  |4 edt 
700 1 |a Sandomenico, Annamaria  |4 edt 
700 1 |a Ruvo, Menotti  |4 oth 
700 1 |a Sandomenico, Annamaria  |4 oth 
245 1 0 |a Monoclonal Antibodies and Their Functional Fragments in Research, Diagnosis and Therapy 2.0 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (112 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Monoclonal antibodies (mAbs) are among the most specialised molecules for the recognition and capture of specific analytes. Hundreds of thousands of mAbs have been generated for a large number of different antigens with increasing affinity and specificity and are available for the most diverse purposes. Many of them have been validated as irreplaceable agents for diagnosis and therapy or as unique reagents for research. Others have been developed using emerging technologies that avoid the need for animal immunisation. This short book strives to gather the perspective view of the various contributing authors and to survey the new strategic assets adopted to generate novel monoclonal antibodies or surrogates, such as Fab, Fab2, ScFv and nanobodies, which have an increasing impact in biomedicine as therapeutic or diagnostic assets in various diseases. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Biology, life sciences  |2 bicssc 
653 |a PRAME 
653 |a mAb 
653 |a bio-layer interferometry 
653 |a epitope identification 
653 |a monoclonal antibody 
653 |a free radical 
653 |a protein aggregation 
653 |a oxidation 
653 |a excipient 
653 |a foot-and-mouth disease virus 
653 |a type O 
653 |a type A 
653 |a phage display 
653 |a antibody 
653 |a competitive ELISA 
653 |a atherosclerosis 
653 |a nano-emulsion 
653 |a magnetic resonance imaging 
653 |a stealth 
653 |a human antibody 
653 |a C. auris 
653 |a candidiasis 
653 |a multidrug resistance 
653 |a monoclonal antibodies 
653 |a universal antibodies 
653 |a cell wall 
653 |a passive immunization 
653 |a cell-based panning 
653 |a semi-automated cell panning 
653 |a FGFR3-specific antibody 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/4986  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/79602  |7 0  |z DOAB: description of the publication